Publikationen (165) Publikationen von EMILIO JOSE GONZALEZ PARRA

2024

  1. Bisphenol A in renal insufficiency: How long will it be used? Is it time to avoid it?

    Nefrologia, Vol. 44, Núm. 3, pp. 313-316

  2. Definition and evolution of the concept of sarcopenia

    Nefrologia

  3. Displacing the Burden: A Review of Protein-Bound Uremic Toxin Clearance Strategies in Chronic Kidney Disease

    Journal of Clinical Medicine, Vol. 13, Núm. 5

  4. Is it possible to reach the catheter target proposed by the guidelines? Reasons for catheter use in prevalent hemodialysis patients

    Nefrologia

2023

  1. A Sarcopenia Index Derived from Malnutrition Parameters in Elderly Haemodialysis Patients

    Nutrients, Vol. 15, Núm. 5

  2. Different Perspectives of Spanish Patients and Professionals on How a Dialysis Unit Should Be Designed

    Patient Preference and Adherence, Vol. 17, pp. 2707-2717

  3. Epidemiology of Fabry disease in patients in hemodialysis in the Madrid community

    Nefrologia, Vol. 43, Núm. 4, pp. 435-441

  4. Impact of the COVID-19 Pandemic in Spain in the Successive Pandemic Waves on Hemodialysis Patients and Healthcare Personnel

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  5. Maintenance of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients after 1273-mRNA SARS-CoV-2 Vaccination

    Pharmaceuticals, Vol. 16, Núm. 4

  6. Recommendations of the Spanish Society of Nephrology for the management of mineral and bone metabolism disorders in patients with chronic kidney disease: 2021 (SEN-MM)

    Nefrologia, Vol. 43, pp. 1-36

  7. The role of bioimpedance analysis in overweight and obese patients with acute heart failure: a pilot study

    ESC Heart Failure, Vol. 10, Núm. 4, pp. 2418-2426

  8. Time-averaged concentration estimation of uraemic toxins with different removal kinetics: a novel approach based on intradialytic spent dialysate measurements

    Clinical Kidney Journal, Vol. 16, Núm. 4, pp. 735-744

  9. Vitamin D, Cellular Senescence and Chronic Kidney Diseases: What Is Missing in the Equation?

    Nutrients, Vol. 15, Núm. 6

2022

  1. Anti-Spike antibodies 3 months after SARS-CoV-2 mRNA vaccine booster dose in patients on hemodialysis: the prospective SENCOVAC study

    Clinical Kidney Journal, Vol. 15, Núm. 10, pp. 1856-1864

  2. Clasificación funcional del paciente anciano en hemodiálisis y su influencia en la individualización del tratamiento

    Enfermeria Nefrologica, Vol. 25, Núm. 1, pp. 29-38

  3. Development of Potent Cellular and Humoral Immune Responses in Long-Term Hemodialysis Patients After 1273-mRNA SARS-CoV-2 Vaccination

    Frontiers in Immunology, Vol. 13

  4. Evaluation of the impact of an intradialytic exercise programme on sarcopaenia in very elderly haemodialysis patients

    Clinical Kidney Journal, Vol. 15, Núm. 8, pp. 1514-1523

  5. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

    Clinical journal of the American Society of Nephrology : CJASN

  6. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 37, Núm. 11, pp. 2253-2263

  7. Impact of renal function on the prognostic value of mineral metabolism in patients with chronic ischaemic heart disease patients with chronic ischaemic heart disease

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 1, pp. 1-9